Bluebird’s Latest Gene Therapy Stumble Will Help Vertex Close The Gap

Gene Therapy Launch Delayed Again

 
• By Andrew McConaghie
  
Bluebird bio
Bluebird's Zynteglo is delayed again, and may not reach its first market until 2022. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip